IMMX
Price
$2.17
Change
-$0.07 (-3.12%)
Updated
Jun 27 closing price
Capitalization
60.08M
67 days until earnings call
RNAC
Price
$10.68
Change
-$0.78 (-6.81%)
Updated
Jun 27 closing price
Capitalization
276.02M
Interact to see
Advertisement

IMMX vs RNAC

Header iconIMMX vs RNAC Comparison
Open Charts IMMX vs RNACBanner chart's image
Immix Biopharma
Price$2.17
Change-$0.07 (-3.12%)
Volume$171.35K
Capitalization60.08M
Cartesian Therapeutics
Price$10.68
Change-$0.78 (-6.81%)
Volume$300.63K
Capitalization276.02M
IMMX vs RNAC Comparison Chart in %
Loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMX vs. RNAC commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Hold and RNAC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (IMMX: $2.15 vs. RNAC: $10.64)
Brand notoriety: IMMX and RNAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 91% vs. RNAC: 296%
Market capitalization -- IMMX: $60.08M vs. RNAC: $276.02M
IMMX [@Biotechnology] is valued at $60.08M. RNAC’s [@Biotechnology] market capitalization is $276.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileRNAC’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • RNAC’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMMX and RNAC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 4 TA indicator(s) are bullish while RNAC’s TA Score has 5 bullish TA indicator(s).

  • IMMX’s TA Score: 4 bullish, 5 bearish.
  • RNAC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than IMMX.

Price Growth

IMMX (@Biotechnology) experienced а -3.79% price change this week, while RNAC (@Biotechnology) price change was +8.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

IMMX is expected to report earnings on Sep 03, 2025.

RNAC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($276M) has a higher market cap than IMMX($60.1M). IMMX YTD gains are higher at: -2.045 vs. RNAC (-40.620). IMMX has higher annual earnings (EBITDA): -21.62M vs. RNAC (-83.55M). RNAC has more cash in the bank: 180M vs. IMMX (15.9M). IMMX has less debt than RNAC: IMMX (1.06M) vs RNAC (14.1M). RNAC has higher revenues than IMMX: RNAC (34.2M) vs IMMX (0).
IMMXRNACIMMX / RNAC
Capitalization60.1M276M22%
EBITDA-21.62M-83.55M26%
Gain YTD-2.045-40.6205%
P/E RatioN/A2.00-
Revenue034.2M-
Total Cash15.9M180M9%
Total Debt1.06M14.1M8%
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMXRNAC
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCDAX185.74N/A
N/A
Vanguard Consumer Discretionary Idx Adm
BMSFX14.64N/A
N/A
MFS Blended Research Mid Cap Eq A
HNRGX28.02N/A
N/A
Hennessy Energy Transition Investor
DPLGX27.37N/A
N/A
Jackson Square Large-Cap Growth IS
SSBIX13.38N/A
N/A
State Street Balanced Index K

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and IMTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and IMTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-3.79%
IMTX - IMMX
32%
Poorly correlated
-3.04%
COGT - IMMX
32%
Poorly correlated
-3.07%
XERS - IMMX
32%
Poorly correlated
-0.84%
RNAC - IMMX
31%
Poorly correlated
-7.20%
SYRE - IMMX
31%
Poorly correlated
-4.99%
More

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with SNPX. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-7.20%
SNPX - RNAC
91%
Closely correlated
+23.37%
ALLR - RNAC
86%
Closely correlated
+1.75%
NRXP - RNAC
86%
Closely correlated
-2.29%
PALI - RNAC
81%
Closely correlated
-1.93%
VRDN - RNAC
44%
Loosely correlated
-1.51%
More